These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27284434)
1. Connexin 43 expression is associated with poor survival in patients with esophageal squamous cell carcinoma. Tanaka T; Kimura M; Ishiguro H; Mizoguchi K; Takeyama H Mol Clin Oncol; 2016 Jun; 4(6):989-993. PubMed ID: 27284434 [TBL] [Abstract][Full Text] [Related]
2. Insight into the Role and Regulation of Gap Junction Genes in Lung Cancer and Identification of Nuclear Cx43 as a Putative Biomarker of Poor Prognosis. Aasen T; Sansano I; Montero MÁ; Romagosa C; Temprana-Salvador J; Martínez-Marti A; Moliné T; Hernández-Losa J; Ramón y Cajal S Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30845770 [TBL] [Abstract][Full Text] [Related]
3. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related]
4. Connexin 43 (Cx43) Expression in Laryngeal Squamous Cell Carcinomas: Preliminary Data on Its Possible Prognostic Role. Puzzo L; Caltabiano R; Parenti R; Trapasso S; Allegra E Head Neck Pathol; 2016 Sep; 10(3):292-7. PubMed ID: 26748803 [TBL] [Abstract][Full Text] [Related]
5. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study. Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919 [TBL] [Abstract][Full Text] [Related]
6. Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells. Shishido SN; Nguyen TA Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840298 [TBL] [Abstract][Full Text] [Related]
7. Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome. Sirnes S; Bruun J; Kolberg M; Kjenseth A; Lind GE; Svindland A; Brech A; Nesbakken A; Lothe RA; Leithe E; Rivedal E Int J Cancer; 2012 Aug; 131(3):570-81. PubMed ID: 21866551 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients. Wang S; Wang Z; Liu X; Liu Y; Jia Y World J Surg; 2015 Jul; 39(7):1773-81. PubMed ID: 25711486 [TBL] [Abstract][Full Text] [Related]
9. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma. Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W Oncology; 2018; 95(5):297-308. PubMed ID: 30134247 [TBL] [Abstract][Full Text] [Related]
10. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Sawey MJ; Goldschmidt MH; Risek B; Gilula NB; Lo CW Mol Carcinog; 1996 Oct; 17(2):49-61. PubMed ID: 8890953 [TBL] [Abstract][Full Text] [Related]
11. The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers-In Vitro Studies. Gurbi B; Brauswetter D; Varga A; Gyulavári P; Pénzes K; Murányi J; Zámbó V; Birtalan E; Krenács T; Becker DL; Csala M; Vályi-Nagy I; Peták I; Dános K Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766723 [TBL] [Abstract][Full Text] [Related]
12. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529 [TBL] [Abstract][Full Text] [Related]
13. Altered gap junctional intercellular communication in neoplastic rat esophageal epithelial cells. Garber SA; Fernstrom MJ; Stoner GD; Ruch RJ Carcinogenesis; 1997 Jun; 18(6):1149-53. PubMed ID: 9214596 [TBL] [Abstract][Full Text] [Related]
14. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance. Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007 [TBL] [Abstract][Full Text] [Related]
15. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Kamibayashi Y; Oyamada Y; Mori M; Oyamada M Carcinogenesis; 1995 Jun; 16(6):1287-97. PubMed ID: 7788845 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38α- and JNK-mediated apoptosis in esophageal squamous cell carcinoma. Liu J; Lv L; Gong J; Tan Y; Zhu Y; Dai Y; Pan X; Huen MSY; Li B; Tsao SW; Huo J; Cheung ALM Int J Cancer; 2018 Jan; 142(1):145-155. PubMed ID: 28905993 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Liu Z; Yang T; Xu Z; Cao X Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379 [TBL] [Abstract][Full Text] [Related]
19. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer. Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532 [TBL] [Abstract][Full Text] [Related]
20. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]